Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.07% Nasdaq Down0.56%

Rexahn Pharmaceuticals, Inc. (RNN)

-NYSE MKT
1.06 Up 0.02(1.92%) 10:33AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development994  781  925  552  
Selling General and Administrative1,329  1,033  979  1,347  
Non Recurring -   -   -   -  
Others9  10  9  9  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,332) (1,824) (1,914) (1,909)
Income from Continuing Operations
Total Other Income/Expenses Net(387)(317)(1,195)379  
Earnings Before Interest And Taxes(2,720)(2,141)(3,109)(1,530)
Interest Expense -   -   -   -  
Income Before Tax(2,720)(2,141)(3,109)(1,530)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,720)(2,141)(3,109)(1,530)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,720) (2,141) (3,109) (1,530)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,720) (2,141) (3,109) (1,530)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.